The store will not work correctly when cookies are disabled.
methyl 3-(2-methoxyethylamino)-2-(5-methyl-1H-imidazol-4-yl)imidazo[1,2-a]pyridine-6-carboxylate
ID: ALA4474792
PubChem CID: 155537055
Max Phase: Preclinical
Molecular Formula: C16H19N5O3
Molecular Weight: 329.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCCNc1c(-c2nc[nH]c2C)nc2ccc(C(=O)OC)cn12
Standard InChI: InChI=1S/C16H19N5O3/c1-10-13(19-9-18-10)14-15(17-6-7-23-2)21-8-11(16(22)24-3)4-5-12(21)20-14/h4-5,8-9,17H,6-7H2,1-3H3,(H,18,19)
Standard InChI Key: IKIJVSZQZFIWKW-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
19.0759 -4.2740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7409 -4.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4087 -4.7547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9955 -3.4853 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8173 -3.4865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1133 -5.3127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5258 -4.0418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8608 -4.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1952 -4.5285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9365 -5.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4835 -5.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2894 -5.7553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5452 -4.9694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9964 -4.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5246 -3.2168 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2384 -2.8031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9567 -3.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6684 -2.8034 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6692 -1.9784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3522 -4.7981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9041 -5.4113 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.7112 -5.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6074 -4.0135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3017 -2.8186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 5 2 0
4 2 1 0
2 3 2 0
3 1 1 0
4 5 1 0
6 10 2 0
9 7 1 0
7 8 2 0
8 6 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 15 1 0
8 1 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
13 20 1 0
20 21 1 0
21 22 1 0
20 23 2 0
5 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.36 | Molecular Weight (Monoisotopic): 329.1488 | AlogP: 1.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 93.54 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.61 | CX Basic pKa: 6.07 | CX LogP: 0.78 | CX LogD: 0.76 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.53 | Np Likeness Score: -1.55 |
References
1. (2018) Inhibitors of trim33 and methods of use, |